Epstein-Barr virus infection leads to partial phenotypic reversion of terminally differentiated malignant B cells

Eleni Anastasiadou, Signe Vaeth, Laura Cuomo, Francesco Boccellato, Sara Vincenti, Mara Cirone, Carlo Presutti, Steffen Junker, Gösta Winberg, Luigi Frati, Paul A. Wade, Alberto Faggioni, Pankaj Trivedi

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The B cell lymphomas associated with Epstein-Barr virus (EBV) are not limited to any specific stage of B cell differentiation but covers widely different B cell phenotypes. In vitro infection of the virus negative tumors with a recombinant EBV strain has provided important insights into virus-tumor interaction. Here, we investigated the interaction between EBV and terminally differentiated tumor derived B cells, namely multiple myeloma (MM). The in vitro EBV infected MM expressed restricted viral latency. Acquisition of the virus was accompanied by a partial reprogramming to a mature B cell phenotype. Thus, the plasma cell markers syndecan-1 (CD138), Blimp1 and MUM1 were downregulated, while expression of HLADR, CIITA and TCL1, which are normally not expressed in plasmacytoid cells, was upregulated. The silenced transcription factor gene encoding Pax5 and its target BLNK were activated. Significantly, the free lambda light chains secreted in the medium were reduced in EBV infected MM clones. Collectively, these results suggest that the restricted EBV latency can cause at least partial phenotypic reversion of terminally differentiated B tumor cells. We suggest that the restricted EBV latent gene expression may not only be the consequence but the cause of the mature B cell phenotype, actively participating in the virus persistence.

Original languageEnglish
Pages (from-to)165-174
Number of pages10
JournalCancer Letters
Volume284
Issue number2
DOIs
Publication statusPublished - Nov 1 2009

Fingerprint

Epstein-Barr Virus Infections
Human Herpesvirus 4
B-Lymphocytes
Multiple Myeloma
Virus Latency
Phenotype
Tumor Virus Infections
Syndecan-1
Viruses
Oncogenic Viruses
B-Cell Lymphoma
Plasma Cells
Cell Differentiation
Neoplasms
Transcription Factors
Down-Regulation
Clone Cells
Gene Expression
Light
Genes

Keywords

  • Differentiation
  • EBV
  • Latency
  • Myeloma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Anastasiadou, E., Vaeth, S., Cuomo, L., Boccellato, F., Vincenti, S., Cirone, M., ... Trivedi, P. (2009). Epstein-Barr virus infection leads to partial phenotypic reversion of terminally differentiated malignant B cells. Cancer Letters, 284(2), 165-174. https://doi.org/10.1016/j.canlet.2009.04.025

Epstein-Barr virus infection leads to partial phenotypic reversion of terminally differentiated malignant B cells. / Anastasiadou, Eleni; Vaeth, Signe; Cuomo, Laura; Boccellato, Francesco; Vincenti, Sara; Cirone, Mara; Presutti, Carlo; Junker, Steffen; Winberg, Gösta; Frati, Luigi; Wade, Paul A.; Faggioni, Alberto; Trivedi, Pankaj.

In: Cancer Letters, Vol. 284, No. 2, 01.11.2009, p. 165-174.

Research output: Contribution to journalArticle

Anastasiadou, E, Vaeth, S, Cuomo, L, Boccellato, F, Vincenti, S, Cirone, M, Presutti, C, Junker, S, Winberg, G, Frati, L, Wade, PA, Faggioni, A & Trivedi, P 2009, 'Epstein-Barr virus infection leads to partial phenotypic reversion of terminally differentiated malignant B cells', Cancer Letters, vol. 284, no. 2, pp. 165-174. https://doi.org/10.1016/j.canlet.2009.04.025
Anastasiadou, Eleni ; Vaeth, Signe ; Cuomo, Laura ; Boccellato, Francesco ; Vincenti, Sara ; Cirone, Mara ; Presutti, Carlo ; Junker, Steffen ; Winberg, Gösta ; Frati, Luigi ; Wade, Paul A. ; Faggioni, Alberto ; Trivedi, Pankaj. / Epstein-Barr virus infection leads to partial phenotypic reversion of terminally differentiated malignant B cells. In: Cancer Letters. 2009 ; Vol. 284, No. 2. pp. 165-174.
@article{0c1d25c5e587451d8d516c8203a15c69,
title = "Epstein-Barr virus infection leads to partial phenotypic reversion of terminally differentiated malignant B cells",
abstract = "The B cell lymphomas associated with Epstein-Barr virus (EBV) are not limited to any specific stage of B cell differentiation but covers widely different B cell phenotypes. In vitro infection of the virus negative tumors with a recombinant EBV strain has provided important insights into virus-tumor interaction. Here, we investigated the interaction between EBV and terminally differentiated tumor derived B cells, namely multiple myeloma (MM). The in vitro EBV infected MM expressed restricted viral latency. Acquisition of the virus was accompanied by a partial reprogramming to a mature B cell phenotype. Thus, the plasma cell markers syndecan-1 (CD138), Blimp1 and MUM1 were downregulated, while expression of HLADR, CIITA and TCL1, which are normally not expressed in plasmacytoid cells, was upregulated. The silenced transcription factor gene encoding Pax5 and its target BLNK were activated. Significantly, the free lambda light chains secreted in the medium were reduced in EBV infected MM clones. Collectively, these results suggest that the restricted EBV latency can cause at least partial phenotypic reversion of terminally differentiated B tumor cells. We suggest that the restricted EBV latent gene expression may not only be the consequence but the cause of the mature B cell phenotype, actively participating in the virus persistence.",
keywords = "Differentiation, EBV, Latency, Myeloma",
author = "Eleni Anastasiadou and Signe Vaeth and Laura Cuomo and Francesco Boccellato and Sara Vincenti and Mara Cirone and Carlo Presutti and Steffen Junker and G{\"o}sta Winberg and Luigi Frati and Wade, {Paul A.} and Alberto Faggioni and Pankaj Trivedi",
year = "2009",
month = "11",
day = "1",
doi = "10.1016/j.canlet.2009.04.025",
language = "English",
volume = "284",
pages = "165--174",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Epstein-Barr virus infection leads to partial phenotypic reversion of terminally differentiated malignant B cells

AU - Anastasiadou, Eleni

AU - Vaeth, Signe

AU - Cuomo, Laura

AU - Boccellato, Francesco

AU - Vincenti, Sara

AU - Cirone, Mara

AU - Presutti, Carlo

AU - Junker, Steffen

AU - Winberg, Gösta

AU - Frati, Luigi

AU - Wade, Paul A.

AU - Faggioni, Alberto

AU - Trivedi, Pankaj

PY - 2009/11/1

Y1 - 2009/11/1

N2 - The B cell lymphomas associated with Epstein-Barr virus (EBV) are not limited to any specific stage of B cell differentiation but covers widely different B cell phenotypes. In vitro infection of the virus negative tumors with a recombinant EBV strain has provided important insights into virus-tumor interaction. Here, we investigated the interaction between EBV and terminally differentiated tumor derived B cells, namely multiple myeloma (MM). The in vitro EBV infected MM expressed restricted viral latency. Acquisition of the virus was accompanied by a partial reprogramming to a mature B cell phenotype. Thus, the plasma cell markers syndecan-1 (CD138), Blimp1 and MUM1 were downregulated, while expression of HLADR, CIITA and TCL1, which are normally not expressed in plasmacytoid cells, was upregulated. The silenced transcription factor gene encoding Pax5 and its target BLNK were activated. Significantly, the free lambda light chains secreted in the medium were reduced in EBV infected MM clones. Collectively, these results suggest that the restricted EBV latency can cause at least partial phenotypic reversion of terminally differentiated B tumor cells. We suggest that the restricted EBV latent gene expression may not only be the consequence but the cause of the mature B cell phenotype, actively participating in the virus persistence.

AB - The B cell lymphomas associated with Epstein-Barr virus (EBV) are not limited to any specific stage of B cell differentiation but covers widely different B cell phenotypes. In vitro infection of the virus negative tumors with a recombinant EBV strain has provided important insights into virus-tumor interaction. Here, we investigated the interaction between EBV and terminally differentiated tumor derived B cells, namely multiple myeloma (MM). The in vitro EBV infected MM expressed restricted viral latency. Acquisition of the virus was accompanied by a partial reprogramming to a mature B cell phenotype. Thus, the plasma cell markers syndecan-1 (CD138), Blimp1 and MUM1 were downregulated, while expression of HLADR, CIITA and TCL1, which are normally not expressed in plasmacytoid cells, was upregulated. The silenced transcription factor gene encoding Pax5 and its target BLNK were activated. Significantly, the free lambda light chains secreted in the medium were reduced in EBV infected MM clones. Collectively, these results suggest that the restricted EBV latency can cause at least partial phenotypic reversion of terminally differentiated B tumor cells. We suggest that the restricted EBV latent gene expression may not only be the consequence but the cause of the mature B cell phenotype, actively participating in the virus persistence.

KW - Differentiation

KW - EBV

KW - Latency

KW - Myeloma

UR - http://www.scopus.com/inward/record.url?scp=69549119991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69549119991&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2009.04.025

DO - 10.1016/j.canlet.2009.04.025

M3 - Article

VL - 284

SP - 165

EP - 174

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -